Advertisement

Psychotropic Agents

Part II: Anxiolytics, Gerontopsychopharmacological Agents, and Psychomotor Stimulants

  • F. Hoffmeister
  • G. Stille

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 55 / 2)

Table of contents

  1. Front Matter
    Pages I-XXVI
  2. Anxiolytics

    1. Front Matter
      Pages 1-1
    2. L. H. Sternbach
      Pages 3-12
    3. W. Haefely, L. Pieri, P. Polc, R. Schaffner
      Pages 13-262
    4. W. Haefely, R. Schaffner, P. Polc, L. Pieri
      Pages 263-283
    5. P. B. Dews
      Pages 285-292
    6. C. Braestrup
      Pages 293-319
    7. S. A. Kaplan, M. L. Jack
      Pages 321-358
    8. L. R. Hines
      Pages 359-393
  3. Gerontopsychopharmacological Agents

    1. Front Matter
      Pages 407-407
    2. D. M. Loew, J. M. Vigouret
      Pages 436-459
    3. F. Hoffmeister, S. Kazda, F. Seuter
      Pages 493-532
  4. Psychomotor Stimulants

  5. Back Matter
    Pages 637-780

About this book

Introduction

This second volume continues the description of the psychotropic agents and discusses anxiolytics, gerontopsychopharmacological agents, and psychomotor stimulants. Of these groups of substances, most of this volume has been devoted to anxiolytics as the authors have endeavored to convey as complete a picture as possible. The editors are of the opinion that particular attention should be given to anxiolytics with regard to their range of administration as this is the most frequently prescribed group of psychotropic drugs. In contrast to neuroleptics and thymoleptics, anxiolytics are a class of psychotropic drugs whose therapeutic effect can be recognized in animal experiments to some extent. This, together with the analysis of the biochemical mechanisms of their actions, permits a better understanding of material processes in the brain accompanying the emotions: anxiety and tension. For the first time in the history of the Handbook the editors have devoted a whole chapter to gerontopsychopharmacological agents. In doing so they are also aware of the risk they are taking, at least from a pharmacological point of view, as gerontopsychopharmacological agents are an insufficiently defined and extremely heterogeneous group of substances. The only denominator the various subgroups of these agents have in common is that they are given in cases of dysfunctions, disorders, and diseases of the brain occurring mainly in the elderly.

Keywords

1,4-Benzodiazepin Acetylcholin Histamin Hormone Hypothalamus Prostaglandin Respiration Serotonin Xanthin chemistry neurotransmitter pharmacodynamics pharmacokinetics pharmacology toxicology

Editors and affiliations

  • F. Hoffmeister
    • 1
  • G. Stille
    • 2
  1. 1.Institut für PharmakologieBayer AGWuppertal 1Germany
  2. 2.Institut für Arzneimittel des BundesgesundheitsamtesBerlin 30Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-67767-0
  • Copyright Information Springer-Verlag Berlin Heidelberg 1981
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-67769-4
  • Online ISBN 978-3-642-67767-0
  • Series Print ISSN 0171-2004
  • Buy this book on publisher's site
Industry Sectors
Pharma
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods